467 related articles for article (PubMed ID: 25970242)
21. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
22. MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis.
Marjon K; Cameron MJ; Quang P; Clasquin MF; Mandley E; Kunii K; McVay M; Choe S; Kernytsky A; Gross S; Konteatis Z; Murtie J; Blake ML; Travins J; Dorsch M; Biller SA; Marks KM
Cell Rep; 2016 Apr; 15(3):574-587. PubMed ID: 27068473
[TBL] [Abstract][Full Text] [Related]
23. The core spliceosome as target and effector of non-canonical ATM signalling.
Tresini M; Warmerdam DO; Kolovos P; Snijder L; Vrouwe MG; Demmers JA; van IJcken WF; Grosveld FG; Medema RH; Hoeijmakers JH; Mullenders LH; Vermeulen W; Marteijn JA
Nature; 2015 Jul; 523(7558):53-8. PubMed ID: 26106861
[TBL] [Abstract][Full Text] [Related]
24. Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis.
Liu F; Cheng G; Hamard PJ; Greenblatt S; Wang L; Man N; Perna F; Xu H; Tadi M; Luciani L; Nimer SD
J Clin Invest; 2015 Sep; 125(9):3532-44. PubMed ID: 26258414
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology: Splicing does the two-step.
Cook-Andersen H; Wilkinson MF
Nature; 2015 May; 521(7552):300-1. PubMed ID: 25970243
[TBL] [Abstract][Full Text] [Related]
26. Targeting MYC in cancer therapy: RNA processing offers new opportunities.
Koh CM; Sabò A; Guccione E
Bioessays; 2016 Mar; 38(3):266-75. PubMed ID: 26778668
[TBL] [Abstract][Full Text] [Related]
27. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
[TBL] [Abstract][Full Text] [Related]
28. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor.
Mounir Z; Korn JM; Westerling T; Lin F; Kirby CA; Schirle M; McAllister G; Hoffman G; Ramadan N; Hartung A; Feng Y; Kipp DR; Quinn C; Fodor M; Baird J; Schoumacher M; Meyer R; Deeds J; Buchwalter G; Stams T; Keen N; Sellers WR; Brown M; Pagliarini RA
Elife; 2016 May; 5():. PubMed ID: 27183006
[TBL] [Abstract][Full Text] [Related]
29. The spliceosome, a potential Achilles heel of MYC-driven tumors.
Anczuków O; Krainer AR
Genome Med; 2015 Oct; 7():107. PubMed ID: 26490253
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
Salton M; Kasprzak WK; Voss T; Shapiro BA; Poulikakos PI; Misteli T
Nat Commun; 2015 May; 6():7103. PubMed ID: 25971842
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide identification of zero nucleotide recursive splicing in Drosophila.
Duff MO; Olson S; Wei X; Garrett SC; Osman A; Bolisetty M; Plocik A; Celniker SE; Graveley BR
Nature; 2015 May; 521(7552):376-9. PubMed ID: 25970244
[TBL] [Abstract][Full Text] [Related]
32. MYC: connecting selective transcriptional control to global RNA production.
Kress TR; Sabò A; Amati B
Nat Rev Cancer; 2015 Oct; 15(10):593-607. PubMed ID: 26383138
[TBL] [Abstract][Full Text] [Related]
33. Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure.
Fernández-Sánchez ME; Barbier S; Whitehead J; Béalle G; Michel A; Latorre-Ossa H; Rey C; Fouassier L; Claperon A; Brullé L; Girard E; Servant N; Rio-Frio T; Marie H; Lesieur S; Housset C; Gennisson JL; Tanter M; Ménager C; Fre S; Robine S; Farge E
Nature; 2015 Jul; 523(7558):92-5. PubMed ID: 25970250
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of the human U snRNP assembly machinery reveals stepwise Sm protein organization.
Neuenkirchen N; Englbrecht C; Ohmer J; Ziegenhals T; Chari A; Fischer U
EMBO J; 2015 Jul; 34(14):1925-41. PubMed ID: 26069323
[TBL] [Abstract][Full Text] [Related]
35. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Lee SC; Dvinge H; Kim E; Cho H; Micol JB; Chung YR; Durham BH; Yoshimi A; Kim YJ; Thomas M; Lobry C; Chen CW; Pastore A; Taylor J; Wang X; Krivtsov A; Armstrong SA; Palacino J; Buonamici S; Smith PG; Bradley RK; Abdel-Wahab O
Nat Med; 2016 Jun; 22(6):672-8. PubMed ID: 27135740
[TBL] [Abstract][Full Text] [Related]
36. SnapShot: Spliceosome Dynamics I.
Wahl MC; Lührmann R
Cell; 2015 Jun; 161(6):1474-e1. PubMed ID: 26046445
[TBL] [Abstract][Full Text] [Related]
37. MYC Regulates Expression of Pre-mRNA Splicing Machinery in Lymphoma.
Cancer Discov; 2015 Jul; 5(7):692. PubMed ID: 25998403
[TBL] [Abstract][Full Text] [Related]
38. Differential expression, distinct localization and opposite effect on Golgi structure and cell differentiation by a novel splice variant of human PRMT5.
Sohail M; Zhang M; Litchfield D; Wang L; Kung S; Xie J
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2444-52. PubMed ID: 26151339
[TBL] [Abstract][Full Text] [Related]
39. Splicing and Dicing MYC-Mediated Synthetic Lethality.
Stine ZE; Dang CV
Cancer Cell; 2015 Oct; 28(4):405-406. PubMed ID: 26461086
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
